Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carol B. Donovan
Observed names:
C B Donovan,
C. B. DONOVAN,
C. B. Donovan,
C. Donovan,
CAROL B. DONOVAN,
Carol B Donovan,
Carol Donovan
show all 7
Institution:
Pfizer (United States)
Observed institutions:
Amgen (United States),
Pfizer (United States),
Wayne State University,
University of Michigan,
Yale University,
Michigan Medicine,
University of Cincinnati
show all 7
OpenAlex ID:
A5044972701
Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response
2002
·
Jeffrey M Labasi
, Nina Petrushova
, et al.
·
The Journal of Immunology
·
544
PDF
Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.
1996
·
A Nguyen
, J C Kath
, et al.
·
Molecular Pharmacology
·
128
A new method for the rapid isolation of basolateral plasma membrane vesicles from rat liver. Characterization, validation, and bile acid transport studies.
1984
·
B L Blitzer
, C B Donovan
·
Journal of Biological Chemistry
·
113
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
2011
·
Ronald P. Gladue
, Timothy Paradis
, et al.
·
Cancer Immunology Immunotherapy
·
73
UK‐78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage‐gated potassium channel and inhibits human T cell activation
1999
·
Douglas C Hanson
, Angela Nguyen
, et al.
·
British Journal of Pharmacology
·
73
PDF
Effects of inhibitors of Na+-coupled ion transport on bile acid uptake by isolated rat hepatocytes
1982
·
B. L. Blitzer
, S. L. Ratoosh
, et al.
·
American Journal of Physiology-Gastrointestinal and Liver Physiology
·
60
Cerebrospinal fluid eicosanoid levels: Endogenous PGD, and LTC, synthesis by antigen‐presenting cells that migrate to the central nervous system
1991
·
Paula Dore-Duffy
, Shih-Yieh Ho
, et al.
·
Neurology
·
59
Microphysiological systems in early stage drug development: Perspectives on current applications and future impact
2021
·
Anna K. Kopec
, Ryuji Yokokawa
, et al.
·
The Journal of Toxicological Sciences
·
44
PDF
Preclinical in vitro characterization of anti-CTLA4 therapeutic antibody CP-675,206.
2004
·
Douglas C. Hanson
, Paul C. Canniff
, et al.
·
Cancer Research
·
40
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
2023
·
Wei Li
, Kimberly K Crouse
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
30
PDF
Human lymphocyte activation assay: Anin vitromethod for predictive immunotoxicity testing
2010
·
Mark Collinge
, Susan H. Cole
, et al.
·
Journal of Immunotoxicology
·
30
PDF
PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases
2010
·
Herbert A. Runnels
, Gregory L. Weber
, et al.
·
Advances in Therapy
·
23
Amino acid inhibition of bile acid uptake by isolated rat hepatocytes: relationship to dissipation of transmembrane Na+ gradient
1983
·
B. L. Blitzer
, S. L. Ratoosh
, et al.
·
American Journal of Physiology-Gastrointestinal and Liver Physiology
·
23
The SAR of UK-78,282: A novel blocker of human T cell Kv1.3 potassium channels
1997
·
Laurence E. Burgess
, Kevin Koch
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
20
Expression of monocyte activation antigen Mo3 on the surface of peripheral blood monocytes from patients with multiple sclerosis
1992
·
Paula Dore-Duffy
, Carol Donovan
, et al.
·
Neurology
·
19
In vivo efficacy of the CD40 agonist antibody CP-870,893 against a broad range of tumor types: Impact of tumor CD40 expression, dendritic cells, and chemotherapy
2006
·
R. P. Gladue
, S. H. Cole
, et al.
·
Journal of Clinical Oncology
·
15
In vitro characterization and pre-clinical pharmacokinetics of CP-870,893, a human anti-CD40 agonist antibody
2006
·
V. Bedian
, C. Donovan
, et al.
·
Journal of Clinical Oncology
·
10
Immunophenotyping of canine T cell activation and proliferation by combined protein and RNA flow cytometry
2024
·
Xu Zhu
, Kara Rogers
, et al.
·
Veterinary Immunology and Immunopathology
·
6
Functional desensitization of monocytes from patients with multiple sclerosis due to prostaglandin E1
1991
·
Paula Dore-Duffy
, Carol Donovan
·
Clinical Immunology and Immunopathology
·
5
Comparison of an Antibody Capture and A Cell Capture Ligand-Binding Assay to Quantify A Monoclonal Therapeutic in Serum
2011
·
Franklin Spriggs
, Poonam Aggarwal
, et al.
·
Bioanalysis
·
4
Development of DQ-MHC Class II Monoclonal Antibodies—A New, Targeted Therapeutic Approach in Type 1 Diabetes
2018
·
ANGELA LOMBARDI
, MING ZHU
, et al.
·
Diabetes
ChemInform Abstract: The SAR of UK‐78,282: A Novel Blocker of Human T Cell Kv1.3 Potassium Channels.
1997
·
L. E. BURGESS
, K. KOCH
, et al.
·
ChemInform
CP-123,369: A potent, orally active immunosuppressive agent
1995
·
K. Koch
, D. C. Hanson
, et al.
·
Inflammation Research
Show more works
View as search
Works count:
23
Citation count:
1,319
H-index:
15
I10-index:
17
Year
Topic
Type